Field: 

  • Cancers
  • Cardiology
  • General practice
  • Infectious disease
  • Internal medicine
  • Liver disease
  • Mental health
  • Primary care
  • Public health
  • Respiratory and Thoracic

Location: School of Public Health

Type of student: PhD or MPhil only

Type of work: Statistical analysis 

This is a clinical trial of nicotine vaporisers (e-cigarettes) being tested as a smoking cessation aid among populations that have high smoking prevalence: People living with HIV, hepatitis C or opiate dependence. This project is funded by a NHMRC project grant. A top-up scholarship is available for high quality applicants.

Smoking is a leading cause of preventable death for priority populations with comorbidities (HIV, Hepatitis C and Opiate dependence) due to their high smoking prevalence, greater vulnerability to tobacco-related disease and low quit rates with current cessation therapies. This research will provide robust evidence on the effectiveness, safety and cost-effectiveness of offering nicotine maintenance in addition to standard cessation treatment to people living with comorbidities.

This project responds to international calls improve quit rates among smokers with co-morbidities and calls from government and public health organisations (e.g. WHO, RACP, NHMRC) for research on the safety and efficacy of nicotine vaporisers to be prioritised.

This pragmatic, open-label randomised partial cross-over trial aims to evaluate if adding a nicotine vaporiser intervention to a standard quit smoking support intervention improves quit rates for these populations and whether offering both interventions concurrently is more effective and cost-effective than offering the interventions sequentially.

Prerequisite skills: Statistical analysis skills would be useful as this PhD will involve data analysis.

Time frame: Participant recruitment is expected to commence in early 2018.